CareersPAVmed and Lucid Diagnostics name two new IR hires Jan 13, 2022Garnet RoachMedical technology company PAVmed and its majority-owned subsidiary Lucid Diagnostics, a commercial-stage cancer prevention...Read more
CareersCosmo Pharmaceuticals names new head of IR Dec 30, 2021Garnet RoachDublin, Ireland-headquartered Cosmo Pharmaceuticals has announced a new head of investor relations in Hazel Winchester, who will take...Read more
Small cap‘The pandemic has changed IR’: Thomas Kudsk Larsen on his move from AstraZeneca to small cap Sobi Dec 02, 2021Garnet Roach‘For people doing IR, I think this pandemic has been so fundamental in terms of changing their daily lives,’ says Thomas Kudsk Larsen...Read more
CareersJohnson & Johnson names new head of IR Oct 15, 2021Garnet RoachPharmaceuticals and healthcare giant Johnson & Johnson has named the former Janssen vice president and CFO for EMEA as its new...Read more
Case studies‘We are a flagman for what’s happening’: Roche on being a bellwether in a pandemic Jul 29, 2021Garnet Roach‘So far, we have mostly been right,’ says Karl Mahler, head of IR at Roche , on the pharma giant’s internal simulations looking at...Read more
Case studiesAdvisory Intelligence: ‘Deals and data’ are heartbeat of biotech Jun 08, 2021NASDAQSponsored content For companies in the biotech sector, 2021 is off to a fast start as capital-raising among new issuers...Read more
Shareholder targeting & IDArix Bioscience: Taking on targeting Jul 02, 2018Garnet RoachWhen Charlotte Parry joined London-headquartered small cap Arix Bioscience as IR manager in September 2017, she set about creating a...Read more